- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-mer
- Ligands
- 29 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 26 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
NAG.30: 3 residues within 4Å:- Chain A: Y.34, F.65, N.67
Ligand excluded by PLIPNAG.31: 4 residues within 4Å:- Chain A: N.126, A.127, T.128, N.129
Ligand excluded by PLIPNAG.32: 1 residues within 4Å:- Chain A: N.168
Ligand excluded by PLIPNAG.33: 3 residues within 4Å:- Chain A: G.235, I.236, N.237
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain A: N.606
Ligand excluded by PLIPNAG.35: 1 residues within 4Å:- Chain A: N.660
Ligand excluded by PLIPNAG.36: 5 residues within 4Å:- Chain B: Y.34, N.36, F.65, S.66, N.67
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain B: N.167, N.168
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain B: T.112, N.237, T.239
Ligand excluded by PLIPNAG.39: 6 residues within 4Å:- Chain B: F.341, G.342, F.345, N.346, L.371, S.374
Ligand excluded by PLIPNAG.40: 1 residues within 4Å:- Chain B: N.606
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain B: H.658, N.660
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain C: N.36, F.65, N.67
Ligand excluded by PLIPNAG.43: 3 residues within 4Å:- Chain C: N.126, A.127, N.129
Ligand excluded by PLIPNAG.44: 1 residues within 4Å:- Chain C: N.168
Ligand excluded by PLIPNAG.45: 2 residues within 4Å:- Chain C: I.236, N.237
Ligand excluded by PLIPNAG.46: 5 residues within 4Å:- Chain C: F.345, N.346, S.374, S.376, F.377
Ligand excluded by PLIPNAG.47: 1 residues within 4Å:- Chain C: N.606
Ligand excluded by PLIPNAG.48: 2 residues within 4Å:- Chain C: H.658, N.660
Ligand excluded by PLIPNAG.49: 4 residues within 4Å:- Chain D: N.53, T.55, E.57, Q.340
Ligand excluded by PLIPNAG.50: 3 residues within 4Å:- Chain D: N.90, L.91, T.92
Ligand excluded by PLIPNAG.51: 4 residues within 4Å:- Chain D: Q.101, Q.102, N.103, N.194
Ligand excluded by PLIPNAG.52: 1 residues within 4Å:- Chain D: N.322
Ligand excluded by PLIPNAG.53: 2 residues within 4Å:- Chain D: D.431, N.432
Ligand excluded by PLIPNAG.54: 5 residues within 4Å:- Chain D: K.416, H.417, S.420, S.545, N.546
Ligand excluded by PLIPNAG.55: 4 residues within 4Å:- Chain E: N.53, T.55, E.57, N.58
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yang, T.J. et al., Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function. Nat.Struct.Mol.Biol. (2021)
- Release Date
- 2021-09-01
- Peptides
- Spike glycoprotein: ABC
Angiotensin-converting enzyme 2 (ACE2) ectodomain: DEF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
IE
JF
K
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-mer
- Ligands
- 29 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 26 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yang, T.J. et al., Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function. Nat.Struct.Mol.Biol. (2021)
- Release Date
- 2021-09-01
- Peptides
- Spike glycoprotein: ABC
Angiotensin-converting enzyme 2 (ACE2) ectodomain: DEF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
IE
JF
K